Broker names 3 speculative ASX shares to buy

Here are three speculative shares rated as buys…

| More on:
Man presses green buy button and red sell button on a graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're an investor with a high tolerance for risk, then you may want to look at the ASX shares listed below.

This week the team at Bell Potter put speculative buy ratings on them. Here's what you need to know:

Bubs Australia Ltd (ASX: BUB)

According to the note, Bell Potter has retained its speculative buy rating and lifted its price target on this infant formula company's shares to 70 cents. The broker was pleased with Bubs' better than expected performance during the second quarter and has upgraded its estimates to reflect this.

Bell Potter commented: "BUB delivered another strong quarter of growth in 2Q22, which again has been driven in large by the infant nutrition business. Improving secular trade flows to China, continued signs of brand traction and the potential for BUB to benefit in indirect distribution channels as A2M shifts focus to direct China channels, are supportive of our Buy, Speculative risk rating."

PointsBet Holdings Ltd (ASX: PBH)

Bell Potter has retained its buy rating but cut its price target on this sports betting company's shares to $9.00 following the release of its second quarter update. While the broker felt it was a bit of a mixed quarter, it saw enough in it to remain positive on the future.

It commented: "The key take-out of the Q2 quarterly was the trading metrics in both Australia and the US were good but the market share across most live states in the US continues to weaken."

"We continue to believe PointsBet will be successful in establishing a US business across approximately 18 states and provinces though the market share is unlikely to reach its target of 10%, at least in the short to medium term (i.e. before product becomes the key driver)," the broker added.

Volpara Health Technologies Ltd (ASX: VHT)

Finally, Bell Potter has retained its speculative buy rating and trimmed its price target on this medtech company's shares to $1.30. It notes that the company's shares have been on a downward trajectory over the last 12 months despite its strong growth continuing. Bell Potter appears to believe this could be a buying opportunity for investors.

The broker said: "The company continues to show solid progress in revenue growth and its move toward positive cash flow generation from operations. Notwithstanding, its EV/Revenue multiple has nearly halved over the course of the last year, consistent with many peers in the med tech space."

"VHT has an expanding revenue base and appears to be on a pathway to cash flow breakeven over the course of calendar years 2022/2023. We conclude that the company is well funded in the short term and will continue to expand its revenue footprint both from existing clients and newly business opportunities," it added.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Pointsbet Holdings Ltd and VOLPARA FPO NZ. The Motley Fool Australia owns and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended BUBS AUST FPO and Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

These ASX 200 shares could rise 20% to 50%

Big returns could be on the cards for owners of these shares according to analysts.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Why this ASX 100 stock can rise 14% to a new 52-week high

Goldman Sachs thinks investors should be buying this top stock now.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Goldman says buy this ASX 200 share for a 14% annual return

This overlooked stock could be a good option for investors according to the broker.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A wine technician in overalls holds a glass of red wine up to the light and studies is closely with large wine barrels in the background, stored in a brick walled wine cellar.
Broker Notes

2 undervalued ASX 200 shares with 'significant catalysts ahead'

We reveal the ASX 200 coal and wine stocks that this fund manager has selected for additional investment.

Read more »

A female coal miner wearing a white hardhat and orange high-vis vest holds a lump of coal and smiles as the Whitehaven Coal share price rises today
Broker Notes

1 ASX 200 energy stock with 'minimal competition' to buy right now

This stock is trading 30% lower than its 2022 record high.

Read more »

happy investor, share price rise, increase, up
Broker Notes

These ASX 200 shares could rise 25% to 50%

Analysts believe these shares could deliver big returns for investors.

Read more »